Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
Gilde Healthcare’s Investment in Swiss Dental Solutions
Chiesi Farmaceutici S.p.A.’s Acquisition of Raxone/idebenone From Santhera Pharmaceuticals AG
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...